307 related articles for article (PubMed ID: 31137526)
1. CO-Releasing Materials: An Emphasis on Therapeutic Implications, as Release and Subsequent Cytotoxicity Are the Part of Therapy.
Faizan M; Muhammad N; Niazi KUK; Hu Y; Wang Y; Wu Y; Sun H; Liu R; Dong W; Zhang W; Gao Z
Materials (Basel); 2019 May; 12(10):. PubMed ID: 31137526
[TBL] [Abstract][Full Text] [Related]
2. Water-Soluble Carbon Monoxide-Releasing Molecules (CORMs).
Khan H; Faizan M; Niazi SUK; Madiha ; Muhammad N; Zhang W
Top Curr Chem (Cham); 2022 Dec; 381(1):3. PubMed ID: 36515756
[TBL] [Abstract][Full Text] [Related]
3. Examining the antimicrobial activity and toxicity to animal cells of different types of CO-releasing molecules.
Nobre LS; Jeremias H; Romão CC; Saraiva LM
Dalton Trans; 2016 Jan; 45(4):1455-66. PubMed ID: 26673556
[TBL] [Abstract][Full Text] [Related]
4. Development of Triggerable, Trackable, and Targetable Carbon Monoxide Releasing Molecules.
Lazarus LS; Benninghoff AD; Berreau LM
Acc Chem Res; 2020 Oct; 53(10):2273-2285. PubMed ID: 32929957
[TBL] [Abstract][Full Text] [Related]
5. Plight of CORMs: The unreliability of four commercially available CO-releasing molecules, CORM-2, CORM-3, CORM-A1, and CORM-401, in studying CO biology.
Bauer N; Yuan Z; Yang X; Wang B
Biochem Pharmacol; 2023 Aug; 214():115642. PubMed ID: 37321416
[TBL] [Abstract][Full Text] [Related]
6. Effects of frequently applied carbon monoxide releasing molecules (CORMs) in typical CO-sensitive model systems - A comparative in vitro study.
Stucki D; Krahl H; Walter M; Steinhausen J; Hommel K; Brenneisen P; Stahl W
Arch Biochem Biophys; 2020 Jul; 687():108383. PubMed ID: 32335048
[TBL] [Abstract][Full Text] [Related]
7. CO-releasing molecule (CORM) conjugate systems.
Kautz AC; Kunz PC; Janiak C
Dalton Trans; 2016 Nov; 45(45):18045-18063. PubMed ID: 27808304
[TBL] [Abstract][Full Text] [Related]
8. Controlled therapeutic delivery of CO from carbon monoxide-releasing molecules (CORMs).
Choi HI; Zeb A; Kim MS; Rana I; Khan N; Qureshi OS; Lim CW; Park JS; Gao Z; Maeng HJ; Kim JK
J Control Release; 2022 Oct; 350():652-667. PubMed ID: 36063960
[TBL] [Abstract][Full Text] [Related]
9. Carbon Monoxide and Its Controlled Release: Therapeutic Application, Detection, and Development of Carbon Monoxide Releasing Molecules (CORMs).
Ling K; Men F; Wang WC; Zhou YQ; Zhang HW; Ye DW
J Med Chem; 2018 Apr; 61(7):2611-2635. PubMed ID: 28876065
[TBL] [Abstract][Full Text] [Related]
10. Nonmetallic carbon monoxide releasing molecules (CORMs).
Abeyrathna N; Washington K; Bashur C; Liao Y
Org Biomol Chem; 2017 Oct; 15(41):8692-8699. PubMed ID: 28948260
[TBL] [Abstract][Full Text] [Related]
11. Reassessing CORM-A1: redox chemistry and idiosyncratic CO-releasing characteristics of the widely used carbon monoxide donor.
Bauer N; Yang X; Yuan Z; Wang B
Chem Sci; 2023 Mar; 14(12):3215-3228. PubMed ID: 36970102
[TBL] [Abstract][Full Text] [Related]
12. Different design of enzyme-triggered CO-releasing molecules (ET-CORMs) reveals quantitative differences in biological activities in terms of toxicity and inflammation.
Stamellou E; Storz D; Botov S; Ntasis E; Wedel J; Sollazzo S; Krämer BK; van Son W; Seelen M; Schmalz HG; Schmidt A; Hafner M; Yard BA
Redox Biol; 2014; 2():739-48. PubMed ID: 25009775
[TBL] [Abstract][Full Text] [Related]
13. Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications.
Winburn IC; Gunatunga K; McKernan RD; Walker RJ; Sammut IA; Harrison JC
Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):31-41. PubMed ID: 22269084
[TBL] [Abstract][Full Text] [Related]
14. IR spectroscopic methods for the investigation of the CO release from CORMs.
Klein M; Neugebauer U; Gheisari A; Malassa A; Jazzazi TM; Froehlich F; Westerhausen M; Schmitt M; Popp J
J Phys Chem A; 2014 Jul; 118(29):5381-90. PubMed ID: 24978105
[TBL] [Abstract][Full Text] [Related]
15. Carbon-monoxide-releasing molecules for the delivery of therapeutic CO in vivo.
García-Gallego S; Bernardes GJ
Angew Chem Int Ed Engl; 2014 Sep; 53(37):9712-21. PubMed ID: 25070185
[TBL] [Abstract][Full Text] [Related]
16. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.
Motterlini R; Sawle P; Hammad J; Bains S; Alberto R; Foresti R; Green CJ
FASEB J; 2005 Feb; 19(2):284-6. PubMed ID: 15556971
[TBL] [Abstract][Full Text] [Related]
17. A thiol-reactive Ru(II) ion, not CO release, underlies the potent antimicrobial and cytotoxic properties of CO-releasing molecule-3.
Southam HM; Smith TW; Lyon RL; Liao C; Trevitt CR; Middlemiss LA; Cox FL; Chapman JA; El-Khamisy SF; Hippler M; Williamson MP; Henderson PJF; Poole RK
Redox Biol; 2018 Sep; 18():114-123. PubMed ID: 30007887
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances on Carbon Monoxide Releasing Molecules for Antibacterial Applications.
Cheng J; Hu J
ChemMedChem; 2021 Dec; 16(24):3628-3634. PubMed ID: 34613654
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of CORM-2, CORM-3 and CORM-A1 on coagulation in human plasma.
Nielsen VG; Garza JI
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):801-5. PubMed ID: 25058038
[TBL] [Abstract][Full Text] [Related]
20. CO-Releasing Molecules Have Nonheme Targets in Bacteria: Transcriptomic, Mathematical Modeling and Biochemical Analyses of CORM-3 [Ru(CO)3Cl(glycinate)] Actions on a Heme-Deficient Mutant of Escherichia coli.
Wilson JL; Wareham LK; McLean S; Begg R; Greaves S; Mann BE; Sanguinetti G; Poole RK
Antioxid Redox Signal; 2015 Jul; 23(2):148-62. PubMed ID: 25811604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
